Researchers in Singapore have developed an ultrasensitive method to detect micro-RNAs: tiny molecules that can indicate the presence of tumours. They are applying the technology toward a non-invasive screening test for gastric cancer.
In 2012, 8.2 million lives were lost to cancer around the world. This number is expected to double by 2030. However, many cancer deaths could be prevented if the disease was detected earlier.
To improve cancer detection, researchers in Singapore have developed a new method for diagnosing cancer non-invasively. It involves detecting micro-RNAs (miRNAs): small, non-coding RNA molecules that are important in the regulation of gene expression. Certain abnormalities that can occur in miRNAs have been implicated in various diseases, including cancer.
Research has shown that miRNA molecules are incredibly stable in blood, making them an excellent biomarker of disease. In fact, tumour-specific miRNAs have recently been reported. However, these molecules are difficult to detect because they are present at extremely low levels in the blood.
Researchers from the Agency for Science, Technology and Research (A*STAR) Bioprocessing Technology Institute and the National University of Singapore have developed an algorithm and miRNAdetection technology that is much more sensitive than those currently in use.
The technology, which is compatible with existing laboratory instruments, can measure hundreds of miRNAs from a few drops of blood with unparalleled precision, sensitivity and speed.
The researchers, who have since spun off MiRXES, a biotechnology startup, are now working with the Singapore Gastric Cancer Consortium and the A*STAR Diagnostic Development Hub to develop a test that detects gastric cancer before symptoms appear.
A clinical study involving thousands of patients is in the planning phases. If successful, it will be the first noninvasive screening test for gastric cancer: the second deadliest cancer worldwide and one with a particularly high prevalence among Asian populations.
For further information contact:
Professor Too Heng-Phon
Bioprocessing Technology Institute, Agency for Science,
Technology and Research (A*STAR) and Department of
Biochemistry, Yong Loo Lin School of Medicine
National University of Singapore
Dr Lihan Zhou
Co-founder and CTO, MiRXES
*This article also appears in Asia Research News 2015 (p.19).
Virtual Reality in Medicine: New Opportunities for Diagnostics and Surgical Planning
07.12.2016 | Universität Basel
3-D printed kidney phantoms aid nuclear medicine dosing calibration
06.12.2016 | Society of Nuclear Medicine
In recent years, lasers with ultrashort pulses (USP) down to the femtosecond range have become established on an industrial scale. They could advance some applications with the much-lauded “cold ablation” – if that meant they would then achieve more throughput. A new generation of process engineering that will address this issue in particular will be discussed at the “4th UKP Workshop – Ultrafast Laser Technology” in April 2017.
Even back in the 1990s, scientists were comparing materials processing with nanosecond, picosecond and femtosesecond pulses. The result was surprising:...
Have you ever wondered how you see the world? Vision is about photons of light, which are packets of energy, interacting with the atoms or molecules in what...
A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.
Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...
In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.
“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...
The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.
The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...
16.11.2016 | Event News
01.11.2016 | Event News
14.10.2016 | Event News
08.12.2016 | Life Sciences
08.12.2016 | Physics and Astronomy
08.12.2016 | Materials Sciences